Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm133691.htm

Ig is approved for some demyelinating diseases and used off label now for certain forms of MS. It would be easy to expand hyqvia's indication into those Gammaguard already has approval for. What could be exciting would be if this new convenient form of Ig might make it now practical to use for the more common forms of MS. This indication would require trials but Baxter may have that in mind. And then, of course, is the possibility they might trial Hqvia in a subset of Alzheimer's.

It is possible that by the time Baxter has their Georgia plant up and running, and the Ig supply is no longer an issue, Hyqvia will have a few more indications...